{"id":369612,"date":"2025-09-01T19:58:24","date_gmt":"2025-09-01T19:58:24","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-abbott-laboratories-2\/"},"modified":"2025-09-01T19:58:24","modified_gmt":"2025-09-01T19:58:24","slug":"how-to-buy-abbott-laboratories-2","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/","title":{"rendered":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-369612","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Abbott Laboratories (0Q15) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 verin. G\u00fcncel hisse performans\u0131n\u0131, b\u00fcy\u00fcme potansiyelini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Abbott Laboratories (0Q15) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 verin. G\u00fcncel hisse performans\u0131n\u0131, b\u00fcy\u00fcme potansiyelini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Abbott Laboratories, t\u0131bbi sekt\u00f6rde en istikrarl\u0131 ve dinamik f\u0131rsatlardan birini temsil ediyor. 135 y\u0131l\u0131 a\u015fk\u0131n deneyimi ve tan\u0131, t\u0131bbi cihazlar, beslenme ve ila\u00e7 alanlar\u0131n\u0131 kapsayan \u00e7e\u015fitlendirilmi\u015f portf\u00f6y\u00fc ile bu \u015firket her g\u00fcn milyonlarca insan\u0131n hayat\u0131na dokunuyor. Uzun vadeli servet olu\u015fturuyor ya da sa\u011fl\u0131k sekt\u00f6r\u00fcndeki b\u00fcy\u00fcmeye maruz kalmak istiyorsan\u0131z, Abbott Laboratories (0Q15) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 anlamak ak\u0131ll\u0131 yat\u0131r\u0131m i\u00e7in kap\u0131n\u0131z\u0131 aralayabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Abbott Laboratories, t\u0131bbi sekt\u00f6rde en istikrarl\u0131 ve dinamik f\u0131rsatlardan birini temsil ediyor. 135 y\u0131l\u0131 a\u015fk\u0131n deneyimi ve tan\u0131, t\u0131bbi cihazlar, beslenme ve ila\u00e7 alanlar\u0131n\u0131 kapsayan \u00e7e\u015fitlendirilmi\u015f portf\u00f6y\u00fc ile bu \u015firket her g\u00fcn milyonlarca insan\u0131n hayat\u0131na dokunuyor. Uzun vadeli servet olu\u015fturuyor ya da sa\u011fl\u0131k sekt\u00f6r\u00fcndeki b\u00fcy\u00fcmeye maruz kalmak istiyorsan\u0131z, Abbott Laboratories (0Q15) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 anlamak ak\u0131ll\u0131 yat\u0131r\u0131m i\u00e7in kap\u0131n\u0131z\u0131 aralayabilir."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Zamanlamas\u0131<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla Abbott Laboratories (ABT), NYSE'de <strong>132,66 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi; \u015fu anda 52 haftal\u0131k en y\u00fcksek seviyesi olan 141,23 $'\u0131n sadece %6,5 alt\u0131nda ve 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesinin \u00fczerinde rahat bir %16,4 marjla bulunuyor.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>15 Ekim 2025<\/strong> tarihini i\u015faretleyin! Abbott'un 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Tarihsel veriler, bu a\u00e7\u0131klamalar\u0131n genellikle \u00f6nemli fiyat hareketlerine yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> <h3>Kazan\u00e7 Etkisi Analizi: Tarihten Dersler<\/h3> <p>Son \u00e7eyrek raporlar\u0131na bak\u0131ld\u0131\u011f\u0131nda ilgin\u00e7 desenler ortaya \u00e7\u0131k\u0131yor:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><th>\u00d6nemli \u0130\u00e7g\u00f6r\u00fc<\/th><\/tr> <\/thead> <tbody> <tr><td>17 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>137,41 $<\/td><td>\u00d6n Piyasa %5 D\u00fc\u015f\u00fc\u015f<\/td><td>Tahminleri a\u015ft\u0131 ancak temkinli rehberlik yat\u0131r\u0131mc\u0131lar\u0131 korkuttu<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>128,50 $<\/td><td>Haftal\u0131k %3,2 Art\u0131\u015f<\/td><td>G\u00fc\u00e7l\u00fc cihaz sat\u0131\u015flar\u0131 iyimserli\u011fi art\u0131rd\u0131<\/td><\/tr> <tr><td>Ocak 2025<\/td><td>Y\u0131ll\u0131k Rehberlik<\/td><td>125,80 $<\/td><td>Ayl\u0131k %4,5 Art\u0131\u015f<\/td><td>T\u0131bbi cihazlar i\u00e7in olumlu g\u00f6r\u00fcn\u00fcm<\/td><\/tr> <tr><td>Ekim 2024<\/td><td>3. \u00c7eyrek 2024<\/td><td>121,30 $<\/td><td>Haftal\u0131k %2,8 Art\u0131\u015f<\/td><td>Diyabet bak\u0131m\u0131ndaki b\u00fcy\u00fcme piyasalar\u0131 etkiledi<\/td><\/tr> <tr><td>Temmuz 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>118,90 $<\/td><td>%1,9 Art\u0131\u015f<\/td><td>B\u00f6l\u00fcmler aras\u0131nda istikrarl\u0131 performans<\/td><\/tr> <tr><td>Nisan 2024<\/td><td>1. \u00c7eyrek 2024<\/td><td>115,20 $<\/td><td>%3,1 Art\u0131\u015f<\/td><td>Geli\u015fmekte olan piyasalarda g\u00fc\u00e7 vurguland\u0131<\/td><\/tr> <\/tbody> <\/table> <p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %3-6 oran\u0131nda art\u0131r\u0131rken, temkinli rehberlik (iyi sonu\u00e7larla bile) k\u0131sa vadede %4-7 aras\u0131nda d\u00fc\u015f\u00fc\u015flere neden olabilir. Temmuz 2025'te tahminlerin a\u015f\u0131lmas\u0131na ra\u011fmen ya\u015fanan d\u00fc\u015f\u00fc\u015f, ileriye d\u00f6n\u00fck a\u00e7\u0131klamalar\u0131n tarihsel performanstan daha \u00f6nemli oldu\u011funu g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Performans Yolculu\u011fu (Mart-Eyl\u00fcl 2025)<\/h2> <p>Abbott hissesi, y\u0131lba\u015f\u0131ndan bu yana etkileyici bir <strong>%18 getiri<\/strong> sa\u011flad\u0131 ve S&P 500'\u00fcn %6'l\u0131k b\u00fcy\u00fcmesini \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. \u0130\u015fte yolculu\u011fun detaylar\u0131:<\/p> <table> <thead> <tr><th>D\u00f6nem<\/th><th>Fiyat Seviyesi<\/th><th>Temel S\u00fcr\u00fcc\u00fc<\/th><\/tr> <\/thead> <tbody> <tr><td>Mart 2025<\/td><td>138,95 $ (T\u00fcm Zamanlar\u0131n En Y\u00fckse\u011fi)<\/td><td>T\u0131bbi cihaz sat\u0131\u015flar\u0131nda %14,8 art\u0131\u015f<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>134,20 $<\/td><td>Zirve sonras\u0131 piyasa konsolidasyonu<\/td><\/tr> <tr><td>May\u0131s 2025<\/td><td>130,50 $<\/td><td>Daha geni\u015f sa\u011fl\u0131k sekt\u00f6r\u00fc ayarlamas\u0131<\/td><\/tr> <tr><td>Haziran 2025<\/td><td>128,80 $<\/td><td>Yaz volatilite d\u00f6nemi<\/td><\/tr> <tr><td>Temmuz 2025<\/td><td>132,10 $<\/td><td>2. \u00e7eyrek kazan\u00e7 beklentisi<\/td><\/tr> <tr><td>A\u011fustos 2025<\/td><td>131,37 $<\/td><td>Kazan\u00e7 sonras\u0131 sindirim<\/td><\/tr> <tr><td>1 Eyl\u00fcl 2025<\/td><td>132,66 $<\/td><td>\u0130yile\u015fme ivmesi olu\u015fuyor<\/td><\/tr> <\/tbody> <\/table> <p>Hissenin dayan\u0131kl\u0131l\u0131\u011f\u0131, Abbott'un \u00e7e\u015fitlendirilmi\u015f i\u015f modeli sayesinde: Tan\u0131 alan\u0131 COVID testlerindeki azalmadan olumsuz etkilenirken, t\u0131bbi cihazlar %13,4 b\u00fcy\u00fcme ile a\u00e7\u0131\u011f\u0131 kapatt\u0131. Bu dengeli yakla\u015f\u0131m ABT'yi sekt\u00f6r bazl\u0131 zorluklara kar\u015f\u0131 daha az savunmas\u0131z k\u0131l\u0131yor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 Stratejik G\u00f6r\u00fcn\u00fcm<\/h2> <p>Kapsaml\u0131 analist konsens\u00fcs\u00fc ve mevcut temel veriler \u0131\u015f\u0131\u011f\u0131nda beklentiler \u015funlar:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 142-145 $ aral\u0131\u011f\u0131 (mevcut seviyeden %7-9 art\u0131\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br> Gerek\u00e7e: 4. \u00e7eyrek genellikle t\u0131bbi cihazlar i\u00e7in en g\u00fc\u00e7l\u00fc d\u00f6nem, tatil sezonu beslenme sat\u0131\u015flar\u0131n\u0131 art\u0131r\u0131r<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 190-195 $ aral\u0131\u011f\u0131 (mevcutten %43-47 art\u0131\u015f)<br> Kataliz\u00f6rler: Diyabet bak\u0131m\u0131nda yeni \u00fcr\u00fcn lansmanlar\u0131, geli\u015fmekte olan pazar geni\u015flemesi<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 220-225 $ aral\u0131\u011f\u0131 (mevcutten %66-70 art\u0131\u015f)<br> B\u00fcy\u00fcme S\u00fcr\u00fcc\u00fcleri: Ya\u015flanan n\u00fcfus talebi, kardiyak bak\u0131mda teknolojik yenilikler<\/li> <li><strong>2030 Vizyonu<\/strong>: 140-145 $ aral\u0131\u011f\u0131 (temkinli) ile 155-160 $ (iyimser)<br> Dikkate Al\u0131nacaklar: Piyasa doygunlu\u011fu potansiyeli ve inovasyon at\u0131l\u0131mlar\u0131<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Mevcut seviyeler uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel giri\u015f noktas\u0131 sunuyor. 2026-2028 d\u00f6nemi, demografik trendler ve \u00fcr\u00fcn hatt\u0131 nedeniyle \u00f6zellikle umut verici g\u00f6r\u00fcn\u00fcyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Olas\u0131 Zorluklarda Yol Alma<\/h2> <h3>Ba\u015fl\u0131ca Risk Fakt\u00f6rleri<\/h3> <ol> <li><strong>Reg\u00fclasyon De\u011fi\u015fiklikleri<\/strong>: Sa\u011fl\u0131k politikalar\u0131ndaki de\u011fi\u015fiklikler fiyatland\u0131rma ve geri \u00f6deme s\u00fcre\u00e7lerini etkileyebilir<\/li> <li><strong>D\u00f6viz Kuru Riski<\/strong>: %70 uluslararas\u0131 gelir, d\u00f6viz volatilitesi riski yarat\u0131yor<\/li> <li><strong>Rekabetin Artmas\u0131<\/strong>: Diyabet izleme ve kardiyak cihazlarda yeni oyuncular<\/li> <li><strong>Tedarik Zinciri Kesintileri<\/strong>: K\u00fcresel operasyonlar jeopolitik gerilimlere kar\u015f\u0131 hassas<\/li> <li><strong>\u00dcr\u00fcn Sorumlulu\u011fu<\/strong>: T\u0131bbi cihaz geri \u00e7a\u011f\u0131rmalar\u0131 itibar ve maliyetleri ciddi etkileyebilir<\/li> <\/ol> <h3>2025 \u0130\u00e7in Pozitif Sinyaller<\/h3> <ol> <li><strong>T\u0131bbi Cihaz Momentum<\/strong>: ABD'de %14,8 b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc talebi g\u00f6steriyor<\/li> <li><strong>Geli\u015fmekte Olan Pazar G\u00fcc\u00fc<\/strong>: Asya ve Latin Amerika'da %8,7 organik b\u00fcy\u00fcme<\/li> <li><strong>\u0130novasyon Hatt\u0131<\/strong>: 2025 boyunca yeni \u00fcr\u00fcn onaylar\u0131<\/li> <li><strong>Marj Geni\u015flemesi<\/strong>: Faaliyet marjlar\u0131nda 100 baz puan iyile\u015fme<\/li> <li><strong>Temett\u00fc Tutarl\u0131l\u0131\u011f\u0131<\/strong>: 405. ard\u0131\u015f\u0131k \u00e7eyrek temett\u00fc bildirimi<\/li> <\/ol> <h2>\ud83d\udcf0 \u00d6nemli Haber Analizi: Son Alt\u0131 Ay<\/h2> <h3>2. \u00c7eyrek 2025 Kazan\u00e7 Derinlemesine \u0130nceleme (17 Temmuz 2025)<\/h3> <p>Abbott klasik bir \"a\u015fma ve d\u00fc\u015f\u00fc\u015f\" senaryosu sundu: 2. \u00e7eyrek tahminlerini a\u015farken temkinli ileriye d\u00f6n\u00fck rehberlik verdi. 11,14 milyar $ gelir beklentileri %0,6 a\u015ft\u0131, d\u00fczeltilmi\u015f hisse ba\u015f\u0131 kazan\u00e7 (EPS) 1,26 $ tahminleri %0,8 ge\u00e7ti. Ancak temkinli 3. \u00e7eyrek g\u00f6r\u00fcn\u00fcm\u00fc nedeniyle hisse \u00f6n piyasada %5 d\u00fc\u015ft\u00fc.<\/p> <p><strong>T\u00fcccar Notu<\/strong>: Bu potansiyel bir al\u0131m f\u0131rsat\u0131 yarat\u0131r. Sa\u011flam \u015firketler, temel sorunlar yerine rehberlik endi\u015feleri nedeniyle k\u0131sa vadeli d\u00fc\u015f\u00fc\u015fler ya\u015fad\u0131\u011f\u0131nda, genellikle m\u00fckemmel giri\u015f noktalar\u0131 sunar.<\/p> <h3>Operasyonel \u00d6ne \u00c7\u0131kanlar<\/h3> <ul> <li><strong>T\u0131bbi Cihazlar<\/strong>: %13,4 b\u00fcy\u00fcme, diyabet bak\u0131m\u0131ndan kaynakl\u0131 %21,4 art\u0131\u015f<\/li> <li><strong>Geli\u015fmekte Olan Pazarlar<\/strong>: Asya ve Latin Amerika'da %8,7 organik b\u00fcy\u00fcme<\/li> <li><strong>Marj \u0130yile\u015ftirmesi<\/strong>: Hem br\u00fct hem faaliyet marjlar\u0131nda 100 baz puan art\u0131\u015f<\/li> <\/ul> <h3>\u0130\u00e7eriden \u0130\u015flem Faaliyetleri Ba\u011flam\u0131<\/h3> <p>8 A\u011fustos 2025 tarihli Form 144 dosyas\u0131nda 5.550 hisse (746.758 $ de\u011ferinde) sat\u0131\u015f\u0131 rutin hak kazanm\u0131\u015f hisse sat\u0131\u015flar\u0131n\u0131 temsil ediyor, endi\u015fe verici i\u00e7eriden bilgi kullan\u0131m\u0131 davran\u0131\u015f\u0131 de\u011fil. Y\u00f6neticilerin bu t\u00fcr k\u00fc\u00e7\u00fck i\u015flemleri genellikle temel sorunlar\u0131 i\u015faret etmez.<\/p> <h2>\ud83c\udfaf Yeni Ba\u015flayan T\u00fcccar \u0130\u00e7in Bug\u00fcnk\u00fc Eylem Plan\u0131<\/h2> <h3>Ciddi \u00d6neriler:<\/h3> <ol> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik giri\u015f zamanlamas\u0131 yerine k\u00fc\u00e7\u00fck d\u00fczenli al\u0131mlarla ba\u015flay\u0131n<\/li> <li><strong>Kazan\u00e7 Stratejisi<\/strong>: 15 Ekim civar\u0131nda kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015flerde al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Sekt\u00f6r \u00c7e\u015fitlendirmesi<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fcne maruziyeti toplam portf\u00f6y\u00fcn %20'sinin alt\u0131nda tutun<\/li> <\/ol> <h3>Esprili Tecr\u00fcbeli Yorum:<\/h3> <p>\"ABT ile i\u015flem yapmak g\u00fcvenilir bir partnerle \u00e7\u0131kmak gibidir - her g\u00fcn dramatik havai fi\u015fekler yaratmayabilirler ama piyasa dalgalanmalar\u0131nda ger\u00e7ekten ihtiyac\u0131n\u0131z oldu\u011funda oradalar. Sadece bir gecede rock y\u0131ld\u0131z\u0131 olmalar\u0131n\u0131 beklemeyin!\"<\/p> <h2>\u2705 Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NYSE listeli hisseler ve kesirli hisse sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Genellikle kimlik ve adres kan\u0131t\u0131 belgeleri gerektirir<\/td><\/tr> <tr><td>3<\/td><td>Fon Yat\u0131r\u0131n<\/td><td>Ba\u015flang\u0131\u00e7ta riske atmaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"ABT\" Aramas\u0131 Yap\u0131n<\/td><td>Do\u011fru tan\u0131mlama i\u00e7in sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Sipari\u015f Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve takas s\u00fcresini kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Sat\u0131n Alma \u0130\u015flemini Ger\u00e7ekle\u015ftirin<\/td><td>Sipari\u015fi onaylay\u0131n ve i\u015flem onay\u0131n\u0131 bekleyin<\/td><\/tr> <tr><td>8<\/td><td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td><td>140 $ diren\u00e7 ve 125 $ destek gibi \u00f6nemli seviyeleri izleyin<\/td><\/tr> <tr><td>9<\/td><td>\u0130\u015flemi Belgeleyin<\/td><td>Vergi ama\u00e7lar\u0131 ve performans takibi i\u00e7in kay\u0131t tutun<\/td><\/tr> <tr><td>10<\/td><td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td><td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Uzun Vadeli Yat\u0131r\u0131m\u0131 Nas\u0131l Tamamlar?<\/h2> <p>Abbott Laboratories m\u00fckemmel bir uzun vadeli yat\u0131r\u0131m sunarken, Pocket Option gibi platformlar yeni yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz avantajlar sa\u011flar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile yat\u0131r\u0131m yolculu\u011funuza b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100'den fazla \u00e7ekim y\u00f6ntemi k\u00e2rlar\u0131n\u0131za eri\u015fimde esneklik sa\u011flar<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: <a href=\"\/blog\">Pocket Option blogu<\/a> yat\u0131r\u0131m bilginizi art\u0131rmak i\u00e7in s\u00fcrekli \u00f6\u011frenme f\u0131rsatlar\u0131 sunar<\/li> <\/ul> <p>Geleneksel brokerlar arac\u0131l\u0131\u011f\u0131yla uzun vadeli hisse senedi sahipli\u011fi ile Pocket Option gibi platformlar \u00fczerinden h\u0131zl\u0131 i\u015flem f\u0131rsatlar\u0131n\u0131n birle\u015fimi, servet olu\u015fturmak i\u00e7in dengeli bir yakla\u015f\u0131m yarat\u0131r.<\/p> <h2>\ud83c\udf0d Abbott Laboratories: Sa\u011fl\u0131kta \u0130novasyon Lideri<\/h2> <p>Abbott, d\u00fcnya \u00e7ap\u0131nda 160'tan fazla \u00fclkede faaliyet g\u00f6steren, yakla\u015f\u0131k e\u015fit b\u00fcy\u00fckl\u00fckte d\u00f6rt i\u015f segmentine sahip en \u00e7e\u015fitli sa\u011fl\u0131k \u015firketlerinden biridir. T\u0131bbi cihazlar, tan\u0131, beslenme ve ila\u00e7 alanlar\u0131ndaki stratejik dengesi, ola\u011fan\u00fcst\u00fc istikrar sa\u011flarken k\u00fcresel sa\u011fl\u0131k trendlerine b\u00fcy\u00fcme maruziyeti sunar.<\/p> <p><strong>G\u00fcncel Piyasa Konumu<\/strong>:<\/p> <ul> <li>ABD kardiyovask\u00fcler cihaz pazar\u0131nda %18 pazar pay\u0131<\/li> <li>D\u00fcnyadaki kan arz\u0131n\u0131n yakla\u015f\u0131k yar\u0131s\u0131n\u0131 test ediyor<\/li> <li>Gelirin %70'i uluslararas\u0131 pazarlardan geliyor<\/li> <li>D\u00fcnya genelinde 114.000 \u00e7al\u0131\u015fan<\/li> <\/ul> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Abbott, kalbin sol demet dal\u0131 b\u00f6lgesinde d\u00fcnyada ilk kez kablosuz kalp pili prosed\u00fcrlerini ger\u00e7ekle\u015ftirerek t\u0131bbi tarihe ge\u00e7ti - bu, milyonlarca hasta i\u00e7in kardiyak ritim y\u00f6netiminde devrim yaratabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Zamanlamas\u0131<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla Abbott Laboratories (ABT), NYSE&#8217;de <strong>132,66 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Hisse senedi ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi; \u015fu anda 52 haftal\u0131k en y\u00fcksek seviyesi olan 141,23 $&#8217;\u0131n sadece %6,5 alt\u0131nda ve 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesinin \u00fczerinde rahat bir %16,4 marjla bulunuyor.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>15 Ekim 2025<\/strong> tarihini i\u015faretleyin! Abbott&#8217;un 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Tarihsel veriler, bu a\u00e7\u0131klamalar\u0131n genellikle \u00f6nemli fiyat hareketlerine yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<h3>Kazan\u00e7 Etkisi Analizi: Tarihten Dersler<\/h3>\n<p>Son \u00e7eyrek raporlar\u0131na bak\u0131ld\u0131\u011f\u0131nda ilgin\u00e7 desenler ortaya \u00e7\u0131k\u0131yor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<th>\u00d6nemli \u0130\u00e7g\u00f6r\u00fc<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>17 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>137,41 $<\/td>\n<td>\u00d6n Piyasa %5 D\u00fc\u015f\u00fc\u015f<\/td>\n<td>Tahminleri a\u015ft\u0131 ancak temkinli rehberlik yat\u0131r\u0131mc\u0131lar\u0131 korkuttu<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>128,50 $<\/td>\n<td>Haftal\u0131k %3,2 Art\u0131\u015f<\/td>\n<td>G\u00fc\u00e7l\u00fc cihaz sat\u0131\u015flar\u0131 iyimserli\u011fi art\u0131rd\u0131<\/td>\n<\/tr>\n<tr>\n<td>Ocak 2025<\/td>\n<td>Y\u0131ll\u0131k Rehberlik<\/td>\n<td>125,80 $<\/td>\n<td>Ayl\u0131k %4,5 Art\u0131\u015f<\/td>\n<td>T\u0131bbi cihazlar i\u00e7in olumlu g\u00f6r\u00fcn\u00fcm<\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek 2024<\/td>\n<td>121,30 $<\/td>\n<td>Haftal\u0131k %2,8 Art\u0131\u015f<\/td>\n<td>Diyabet bak\u0131m\u0131ndaki b\u00fcy\u00fcme piyasalar\u0131 etkiledi<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>118,90 $<\/td>\n<td>%1,9 Art\u0131\u015f<\/td>\n<td>B\u00f6l\u00fcmler aras\u0131nda istikrarl\u0131 performans<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2024<\/td>\n<td>1. \u00c7eyrek 2024<\/td>\n<td>115,20 $<\/td>\n<td>%3,1 Art\u0131\u015f<\/td>\n<td>Geli\u015fmekte olan piyasalarda g\u00fc\u00e7 vurguland\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %3-6 oran\u0131nda art\u0131r\u0131rken, temkinli rehberlik (iyi sonu\u00e7larla bile) k\u0131sa vadede %4-7 aras\u0131nda d\u00fc\u015f\u00fc\u015flere neden olabilir. Temmuz 2025&#8217;te tahminlerin a\u015f\u0131lmas\u0131na ra\u011fmen ya\u015fanan d\u00fc\u015f\u00fc\u015f, ileriye d\u00f6n\u00fck a\u00e7\u0131klamalar\u0131n tarihsel performanstan daha \u00f6nemli oldu\u011funu g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Performans Yolculu\u011fu (Mart-Eyl\u00fcl 2025)<\/h2>\n<p>Abbott hissesi, y\u0131lba\u015f\u0131ndan bu yana etkileyici bir <strong>%18 getiri<\/strong> sa\u011flad\u0131 ve S&#038;P 500&#8217;\u00fcn %6&#8217;l\u0131k b\u00fcy\u00fcmesini \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. \u0130\u015fte yolculu\u011fun detaylar\u0131:<\/p>\n<table>\n<thead>\n<tr>\n<th>D\u00f6nem<\/th>\n<th>Fiyat Seviyesi<\/th>\n<th>Temel S\u00fcr\u00fcc\u00fc<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mart 2025<\/td>\n<td>138,95 $ (T\u00fcm Zamanlar\u0131n En Y\u00fckse\u011fi)<\/td>\n<td>T\u0131bbi cihaz sat\u0131\u015flar\u0131nda %14,8 art\u0131\u015f<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>134,20 $<\/td>\n<td>Zirve sonras\u0131 piyasa konsolidasyonu<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>130,50 $<\/td>\n<td>Daha geni\u015f sa\u011fl\u0131k sekt\u00f6r\u00fc ayarlamas\u0131<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>128,80 $<\/td>\n<td>Yaz volatilite d\u00f6nemi<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>132,10 $<\/td>\n<td>2. \u00e7eyrek kazan\u00e7 beklentisi<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>131,37 $<\/td>\n<td>Kazan\u00e7 sonras\u0131 sindirim<\/td>\n<\/tr>\n<tr>\n<td>1 Eyl\u00fcl 2025<\/td>\n<td>132,66 $<\/td>\n<td>\u0130yile\u015fme ivmesi olu\u015fuyor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hissenin dayan\u0131kl\u0131l\u0131\u011f\u0131, Abbott&#8217;un \u00e7e\u015fitlendirilmi\u015f i\u015f modeli sayesinde: Tan\u0131 alan\u0131 COVID testlerindeki azalmadan olumsuz etkilenirken, t\u0131bbi cihazlar %13,4 b\u00fcy\u00fcme ile a\u00e7\u0131\u011f\u0131 kapatt\u0131. Bu dengeli yakla\u015f\u0131m ABT&#8217;yi sekt\u00f6r bazl\u0131 zorluklara kar\u015f\u0131 daha az savunmas\u0131z k\u0131l\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 Stratejik G\u00f6r\u00fcn\u00fcm<\/h2>\n<p>Kapsaml\u0131 analist konsens\u00fcs\u00fc ve mevcut temel veriler \u0131\u015f\u0131\u011f\u0131nda beklentiler \u015funlar:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 142-145 $ aral\u0131\u011f\u0131 (mevcut seviyeden %7-9 art\u0131\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> Gerek\u00e7e: 4. \u00e7eyrek genellikle t\u0131bbi cihazlar i\u00e7in en g\u00fc\u00e7l\u00fc d\u00f6nem, tatil sezonu beslenme sat\u0131\u015flar\u0131n\u0131 art\u0131r\u0131r<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 190-195 $ aral\u0131\u011f\u0131 (mevcutten %43-47 art\u0131\u015f)<br \/> Kataliz\u00f6rler: Diyabet bak\u0131m\u0131nda yeni \u00fcr\u00fcn lansmanlar\u0131, geli\u015fmekte olan pazar geni\u015flemesi<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 220-225 $ aral\u0131\u011f\u0131 (mevcutten %66-70 art\u0131\u015f)<br \/> B\u00fcy\u00fcme S\u00fcr\u00fcc\u00fcleri: Ya\u015flanan n\u00fcfus talebi, kardiyak bak\u0131mda teknolojik yenilikler<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 140-145 $ aral\u0131\u011f\u0131 (temkinli) ile 155-160 $ (iyimser)<br \/> Dikkate Al\u0131nacaklar: Piyasa doygunlu\u011fu potansiyeli ve inovasyon at\u0131l\u0131mlar\u0131<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Mevcut seviyeler uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel giri\u015f noktas\u0131 sunuyor. 2026-2028 d\u00f6nemi, demografik trendler ve \u00fcr\u00fcn hatt\u0131 nedeniyle \u00f6zellikle umut verici g\u00f6r\u00fcn\u00fcyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Olas\u0131 Zorluklarda Yol Alma<\/h2>\n<h3>Ba\u015fl\u0131ca Risk Fakt\u00f6rleri<\/h3>\n<ol>\n<li><strong>Reg\u00fclasyon De\u011fi\u015fiklikleri<\/strong>: Sa\u011fl\u0131k politikalar\u0131ndaki de\u011fi\u015fiklikler fiyatland\u0131rma ve geri \u00f6deme s\u00fcre\u00e7lerini etkileyebilir<\/li>\n<li><strong>D\u00f6viz Kuru Riski<\/strong>: %70 uluslararas\u0131 gelir, d\u00f6viz volatilitesi riski yarat\u0131yor<\/li>\n<li><strong>Rekabetin Artmas\u0131<\/strong>: Diyabet izleme ve kardiyak cihazlarda yeni oyuncular<\/li>\n<li><strong>Tedarik Zinciri Kesintileri<\/strong>: K\u00fcresel operasyonlar jeopolitik gerilimlere kar\u015f\u0131 hassas<\/li>\n<li><strong>\u00dcr\u00fcn Sorumlulu\u011fu<\/strong>: T\u0131bbi cihaz geri \u00e7a\u011f\u0131rmalar\u0131 itibar ve maliyetleri ciddi etkileyebilir<\/li>\n<\/ol>\n<h3>2025 \u0130\u00e7in Pozitif Sinyaller<\/h3>\n<ol>\n<li><strong>T\u0131bbi Cihaz Momentum<\/strong>: ABD&#8217;de %14,8 b\u00fcy\u00fcme g\u00fc\u00e7l\u00fc talebi g\u00f6steriyor<\/li>\n<li><strong>Geli\u015fmekte Olan Pazar G\u00fcc\u00fc<\/strong>: Asya ve Latin Amerika&#8217;da %8,7 organik b\u00fcy\u00fcme<\/li>\n<li><strong>\u0130novasyon Hatt\u0131<\/strong>: 2025 boyunca yeni \u00fcr\u00fcn onaylar\u0131<\/li>\n<li><strong>Marj Geni\u015flemesi<\/strong>: Faaliyet marjlar\u0131nda 100 baz puan iyile\u015fme<\/li>\n<li><strong>Temett\u00fc Tutarl\u0131l\u0131\u011f\u0131<\/strong>: 405. ard\u0131\u015f\u0131k \u00e7eyrek temett\u00fc bildirimi<\/li>\n<\/ol>\n<h2>\ud83d\udcf0 \u00d6nemli Haber Analizi: Son Alt\u0131 Ay<\/h2>\n<h3>2. \u00c7eyrek 2025 Kazan\u00e7 Derinlemesine \u0130nceleme (17 Temmuz 2025)<\/h3>\n<p>Abbott klasik bir &#8220;a\u015fma ve d\u00fc\u015f\u00fc\u015f&#8221; senaryosu sundu: 2. \u00e7eyrek tahminlerini a\u015farken temkinli ileriye d\u00f6n\u00fck rehberlik verdi. 11,14 milyar $ gelir beklentileri %0,6 a\u015ft\u0131, d\u00fczeltilmi\u015f hisse ba\u015f\u0131 kazan\u00e7 (EPS) 1,26 $ tahminleri %0,8 ge\u00e7ti. Ancak temkinli 3. \u00e7eyrek g\u00f6r\u00fcn\u00fcm\u00fc nedeniyle hisse \u00f6n piyasada %5 d\u00fc\u015ft\u00fc.<\/p>\n<p><strong>T\u00fcccar Notu<\/strong>: Bu potansiyel bir al\u0131m f\u0131rsat\u0131 yarat\u0131r. Sa\u011flam \u015firketler, temel sorunlar yerine rehberlik endi\u015feleri nedeniyle k\u0131sa vadeli d\u00fc\u015f\u00fc\u015fler ya\u015fad\u0131\u011f\u0131nda, genellikle m\u00fckemmel giri\u015f noktalar\u0131 sunar.<\/p>\n<h3>Operasyonel \u00d6ne \u00c7\u0131kanlar<\/h3>\n<ul>\n<li><strong>T\u0131bbi Cihazlar<\/strong>: %13,4 b\u00fcy\u00fcme, diyabet bak\u0131m\u0131ndan kaynakl\u0131 %21,4 art\u0131\u015f<\/li>\n<li><strong>Geli\u015fmekte Olan Pazarlar<\/strong>: Asya ve Latin Amerika&#8217;da %8,7 organik b\u00fcy\u00fcme<\/li>\n<li><strong>Marj \u0130yile\u015ftirmesi<\/strong>: Hem br\u00fct hem faaliyet marjlar\u0131nda 100 baz puan art\u0131\u015f<\/li>\n<\/ul>\n<h3>\u0130\u00e7eriden \u0130\u015flem Faaliyetleri Ba\u011flam\u0131<\/h3>\n<p>8 A\u011fustos 2025 tarihli Form 144 dosyas\u0131nda 5.550 hisse (746.758 $ de\u011ferinde) sat\u0131\u015f\u0131 rutin hak kazanm\u0131\u015f hisse sat\u0131\u015flar\u0131n\u0131 temsil ediyor, endi\u015fe verici i\u00e7eriden bilgi kullan\u0131m\u0131 davran\u0131\u015f\u0131 de\u011fil. Y\u00f6neticilerin bu t\u00fcr k\u00fc\u00e7\u00fck i\u015flemleri genellikle temel sorunlar\u0131 i\u015faret etmez.<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayan T\u00fcccar \u0130\u00e7in Bug\u00fcnk\u00fc Eylem Plan\u0131<\/h2>\n<h3>Ciddi \u00d6neriler:<\/h3>\n<ol>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik giri\u015f zamanlamas\u0131 yerine k\u00fc\u00e7\u00fck d\u00fczenli al\u0131mlarla ba\u015flay\u0131n<\/li>\n<li><strong>Kazan\u00e7 Stratejisi<\/strong>: 15 Ekim civar\u0131nda kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015flerde al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Sekt\u00f6r \u00c7e\u015fitlendirmesi<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fcne maruziyeti toplam portf\u00f6y\u00fcn %20&#8217;sinin alt\u0131nda tutun<\/li>\n<\/ol>\n<h3>Esprili Tecr\u00fcbeli Yorum:<\/h3>\n<p>&#8220;ABT ile i\u015flem yapmak g\u00fcvenilir bir partnerle \u00e7\u0131kmak gibidir &#8211; her g\u00fcn dramatik havai fi\u015fekler yaratmayabilirler ama piyasa dalgalanmalar\u0131nda ger\u00e7ekten ihtiyac\u0131n\u0131z oldu\u011funda oradalar. Sadece bir gecede rock y\u0131ld\u0131z\u0131 olmalar\u0131n\u0131 beklemeyin!&#8221;<\/p>\n<h2>\u2705 Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE listeli hisseler ve kesirli hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Genellikle kimlik ve adres kan\u0131t\u0131 belgeleri gerektirir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon Yat\u0131r\u0131n<\/td>\n<td>Ba\u015flang\u0131\u00e7ta riske atmaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;ABT&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Do\u011fru tan\u0131mlama i\u00e7in sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Sipari\u015f Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve takas s\u00fcresini kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n Alma \u0130\u015flemini Ger\u00e7ekle\u015ftirin<\/td>\n<td>Sipari\u015fi onaylay\u0131n ve i\u015flem onay\u0131n\u0131 bekleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td>\n<td>140 $ diren\u00e7 ve 125 $ destek gibi \u00f6nemli seviyeleri izleyin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u0130\u015flemi Belgeleyin<\/td>\n<td>Vergi ama\u00e7lar\u0131 ve performans takibi i\u00e7in kay\u0131t tutun<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Uzun Vadeli Yat\u0131r\u0131m\u0131 Nas\u0131l Tamamlar?<\/h2>\n<p>Abbott Laboratories m\u00fckemmel bir uzun vadeli yat\u0131r\u0131m sunarken, Pocket Option gibi platformlar yeni yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz avantajlar sa\u011flar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile yat\u0131r\u0131m yolculu\u011funuza b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100&#8217;den fazla \u00e7ekim y\u00f6ntemi k\u00e2rlar\u0131n\u0131za eri\u015fimde esneklik sa\u011flar<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: <a href=\"\/blog\">Pocket Option blogu<\/a> yat\u0131r\u0131m bilginizi art\u0131rmak i\u00e7in s\u00fcrekli \u00f6\u011frenme f\u0131rsatlar\u0131 sunar<\/li>\n<\/ul>\n<p>Geleneksel brokerlar arac\u0131l\u0131\u011f\u0131yla uzun vadeli hisse senedi sahipli\u011fi ile Pocket Option gibi platformlar \u00fczerinden h\u0131zl\u0131 i\u015flem f\u0131rsatlar\u0131n\u0131n birle\u015fimi, servet olu\u015fturmak i\u00e7in dengeli bir yakla\u015f\u0131m yarat\u0131r.<\/p>\n<h2>\ud83c\udf0d Abbott Laboratories: Sa\u011fl\u0131kta \u0130novasyon Lideri<\/h2>\n<p>Abbott, d\u00fcnya \u00e7ap\u0131nda 160&#8217;tan fazla \u00fclkede faaliyet g\u00f6steren, yakla\u015f\u0131k e\u015fit b\u00fcy\u00fckl\u00fckte d\u00f6rt i\u015f segmentine sahip en \u00e7e\u015fitli sa\u011fl\u0131k \u015firketlerinden biridir. T\u0131bbi cihazlar, tan\u0131, beslenme ve ila\u00e7 alanlar\u0131ndaki stratejik dengesi, ola\u011fan\u00fcst\u00fc istikrar sa\u011flarken k\u00fcresel sa\u011fl\u0131k trendlerine b\u00fcy\u00fcme maruziyeti sunar.<\/p>\n<p><strong>G\u00fcncel Piyasa Konumu<\/strong>:<\/p>\n<ul>\n<li>ABD kardiyovask\u00fcler cihaz pazar\u0131nda %18 pazar pay\u0131<\/li>\n<li>D\u00fcnyadaki kan arz\u0131n\u0131n yakla\u015f\u0131k yar\u0131s\u0131n\u0131 test ediyor<\/li>\n<li>Gelirin %70&#8217;i uluslararas\u0131 pazarlardan geliyor<\/li>\n<li>D\u00fcnya genelinde 114.000 \u00e7al\u0131\u015fan<\/li>\n<\/ul>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Abbott, kalbin sol demet dal\u0131 b\u00f6lgesinde d\u00fcnyada ilk kez kablosuz kalp pili prosed\u00fcrlerini ger\u00e7ekle\u015ftirerek t\u0131bbi tarihe ge\u00e7ti &#8211; bu, milyonlarca hasta i\u00e7in kardiyak ritim y\u00f6netiminde devrim yaratabilir.<\/p>\n"},"faq":[{"question":"Abbott Laboratories hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"ABT\" sembol\u00fc ile hisseyi aray\u0131n, limit veya piyasa emri verin ve i\u015flemi onaylay\u0131n."},{"question":"Abbott Laboratories hisseleri i\u00e7in en iyi al\u0131m zaman\u0131 ne zaman?","answer":"15 Ekim 2025'te a\u00e7\u0131klanacak 3. \u00e7eyrek kazan\u00e7 raporu \u00f6ncesi ve sonras\u0131 d\u00f6nemler, fiyat hareketleri a\u00e7\u0131s\u0131ndan \u00f6nemli f\u0131rsatlar sunabilir."},{"question":"Abbott Laboratories hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, d\u00f6viz kuru dalgalanmalar\u0131, artan rekabet, tedarik zinciri sorunlar\u0131 ve \u00fcr\u00fcn sorumlulu\u011fu riskleri ba\u015fl\u0131ca risk fakt\u00f6rleridir."},{"question":"Pocket Option platformu Abbott hisseleri yat\u0131r\u0131m\u0131na nas\u0131l yard\u0131mc\u0131 olur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ve e\u011fitim kaynaklar\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in avantajlar sunar."},{"question":"Abbott Laboratories'nin 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 142-145 $, 2026'da 190-195 $, 2028'de 220-225 $ ve 2030'da 140-160 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Abbott Laboratories hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"ABT\" sembol\u00fc ile hisseyi aray\u0131n, limit veya piyasa emri verin ve i\u015flemi onaylay\u0131n."},{"question":"Abbott Laboratories hisseleri i\u00e7in en iyi al\u0131m zaman\u0131 ne zaman?","answer":"15 Ekim 2025'te a\u00e7\u0131klanacak 3. \u00e7eyrek kazan\u00e7 raporu \u00f6ncesi ve sonras\u0131 d\u00f6nemler, fiyat hareketleri a\u00e7\u0131s\u0131ndan \u00f6nemli f\u0131rsatlar sunabilir."},{"question":"Abbott Laboratories hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, d\u00f6viz kuru dalgalanmalar\u0131, artan rekabet, tedarik zinciri sorunlar\u0131 ve \u00fcr\u00fcn sorumlulu\u011fu riskleri ba\u015fl\u0131ca risk fakt\u00f6rleridir."},{"question":"Pocket Option platformu Abbott hisseleri yat\u0131r\u0131m\u0131na nas\u0131l yard\u0131mc\u0131 olur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ve e\u011fitim kaynaklar\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in avantajlar sunar."},{"question":"Abbott Laboratories'nin 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 142-145 $, 2026'da 190-195 $, 2028'de 220-225 $ ve 2030'da 140-160 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T19:58:24+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T19:58:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\",\"name\":\"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-09-01T19:58:24+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/","og_locale":"tr_TR","og_type":"article","og_title":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T19:58:24+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T19:58:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/","name":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-09-01T19:58:24+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":369613,"slug":"how-to-buy-abbott-laboratories-2","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Abbott Laboratories (0Q15) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"pt_AA":{"locale":"pt_AA","id":369610,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Como comprar a\u00e7\u00f5es da Abbott Laboratories (0Q15) - Investimento em a\u00e7\u00f5es da Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=369612"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369612\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=369612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=369612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=369612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}